<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Personal Genomics &#8211; Why 23&amp;Me Doesn&#8217;t Work</title>
	<atom:link href="http://www.medicinethink.com/personal-genomics-why-23me-doesnt-work/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.medicinethink.com/personal-genomics-why-23me-doesnt-work/</link>
	<description>devise and revise.</description>
	<lastBuildDate>Sun, 04 Dec 2011 16:39:54 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
<xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" />
	<item>
		<title>By: John Girard</title>
		<link>http://www.medicinethink.com/personal-genomics-why-23me-doesnt-work/comment-page-1/#comment-17317</link>
		<dc:creator>John Girard</dc:creator>
		<pubDate>Sun, 04 Dec 2011 16:39:54 +0000</pubDate>
		<guid isPermaLink="false">http://www.medicinethink.com/?p=219#comment-17317</guid>
		<description>Interesting take -- thanks for sharing this!

I would argue, though, that 23 &amp; me has a bigger marketing problem than scientific problem.  In fact, I don&#039;t think that the typical consumer of 23 &amp; me&#039;s products cares at all about the nuances of the science -- what the big difference is between causation and correlation, how immature the research is at this point, etc.  From the average consumer perspective, the data is &quot;good enough&quot; (note: I don&#039;t believe this to be true myself -- I just think that the typical consumer won&#039;t make the distinction).  Especially when you see luminaries like Sergei Brin making significant life choices and investments based on these very same markers (http://www.wired.com/magazine/2010/06/ff_sergeys_search/all/1), I think the science issue is relatively less important.

Put another way, my guess is that very few people see the service, get interested, and then say &quot;wait, I&#039;m not going to spend $5/month -- the science is bad.&quot;  Rather, I think that there are not enough people getting to that purchase point to begin with - and that&#039;s a market-size / marketing problem.

If I were 23 &amp; me, I would change up my marketing -- focusing on the heritage and ancestry issues more than the disease markers.</description>
		<content:encoded><![CDATA[<p>Interesting take &#8212; thanks for sharing this!</p>
<p>I would argue, though, that 23 &amp; me has a bigger marketing problem than scientific problem.  In fact, I don&#8217;t think that the typical consumer of 23 &amp; me&#8217;s products cares at all about the nuances of the science &#8212; what the big difference is between causation and correlation, how immature the research is at this point, etc.  From the average consumer perspective, the data is &#8220;good enough&#8221; (note: I don&#8217;t believe this to be true myself &#8212; I just think that the typical consumer won&#8217;t make the distinction).  Especially when you see luminaries like Sergei Brin making significant life choices and investments based on these very same markers (<a href="http://www.wired.com/magazine/2010/06/ff_sergeys_search/all/1" rel="nofollow">http://www.wired.com/magazine/2010/06/ff_sergeys_search/all/1</a>), I think the science issue is relatively less important.</p>
<p>Put another way, my guess is that very few people see the service, get interested, and then say &#8220;wait, I&#8217;m not going to spend $5/month &#8212; the science is bad.&#8221;  Rather, I think that there are not enough people getting to that purchase point to begin with &#8211; and that&#8217;s a market-size / marketing problem.</p>
<p>If I were 23 &amp; me, I would change up my marketing &#8212; focusing on the heritage and ancestry issues more than the disease markers.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: 23andme and Genetic Testing = Consumer Engagement</title>
		<link>http://www.medicinethink.com/personal-genomics-why-23me-doesnt-work/comment-page-1/#comment-10543</link>
		<dc:creator>23andme and Genetic Testing = Consumer Engagement</dc:creator>
		<pubDate>Tue, 11 May 2010 22:58:05 +0000</pubDate>
		<guid isPermaLink="false">http://www.medicinethink.com/?p=219#comment-10543</guid>
		<description>[...] founder and CEO of 23andme gave the keynote on the last day of the conference.  To be fair, in the past I&#8217;ve been skeptical of 23andme &#8211; particularly from a clinical perspective.  And, the MD side of me remains [...]</description>
		<content:encoded><![CDATA[<p>[...] founder and CEO of 23andme gave the keynote on the last day of the conference.  To be fair, in the past I&#8217;ve been skeptical of 23andme &#8211; particularly from a clinical perspective.  And, the MD side of me remains [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: One Argument for Bringing the Bio and Tech Worlds Together</title>
		<link>http://www.medicinethink.com/personal-genomics-why-23me-doesnt-work/comment-page-1/#comment-912</link>
		<dc:creator>One Argument for Bringing the Bio and Tech Worlds Together</dc:creator>
		<pubDate>Wed, 17 Feb 2010 01:54:24 +0000</pubDate>
		<guid isPermaLink="false">http://www.medicinethink.com/?p=219#comment-912</guid>
		<description>[...] approach can help both fields make advances.  Another example would be 23&amp;me. I clearly don’t think much of their business model or clinical relevance – but they did inspire some advances in bioinformatics through employing experienced techies to [...]</description>
		<content:encoded><![CDATA[<p>[...] approach can help both fields make advances.  Another example would be 23&amp;me. I clearly don’t think much of their business model or clinical relevance – but they did inspire some advances in bioinformatics through employing experienced techies to [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

